| 27 Aug, 06:57 pm | — | … | Marksans Pharma Ltd - 524404 - Voting Results Of The 34Th Annual General Meeting Of The Company | bse |
| 26 Aug, 04:21 pm | — | … | Intimation Under Regulation 30 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ESG score by Crisil ESG Ratings & Analytics Ltd | nse |
| 20 Aug, 11:48 am | — | … | Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet Q1 FY 27 Financial Results | nse |
| 20 Aug, 11:42 am | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 13 Aug, 06:47 pm | — | … | Marksans Pharma Limited has informed the Exchange about Link of Recording of Conference call Q1 FY 27 Financial Results | nse |
| 13 Aug, 06:45 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 Aug, 06:33 pm | — | … | Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication for Unaudited financial results for the quarter ended June 30, 2026 | nse |
| 12 Aug, 12:34 pm | — | … | Marksans Pharma Limited has informed the Exchange regarding a press release dated August 12, 2026, titled "Press Release dated 12 August 2026 on the unaudited financial results of the Company for the quarter ended 30 June 2026". | nse |
| 12 Aug, 12:32 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Aug, 12:30 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Aug, 12:30 pm | — | … | Marksans Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 12 Aug, 12:25 pm | — | … | Marksans Pharma Limited has submitted to the Exchange, the unaudited financial results for the quarter ended Jun 30, 2026. | nse |
| 12 Aug, 12:24 pm | — | … | Marksans Pharma Ltd - 524404 - Result For The Quarter Ended June 30, 2026 | bse |
| 12 Aug, 12:19 pm | — | … | Marksans Pharma Ltd - 524404 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12 August 2026 | bse |
| 04 Aug, 12:07 pm | — | … | Marksans Pharma Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report'. | nse |
| 04 Aug, 11:33 am | — | … | Marksans Pharma Ltd - 524404 - Reg. 34 (1) Annual Report. | bse |
| 03 Aug, 06:37 pm | — | … | Marksans Pharma Limited has informed the Exchange about schedule for Q1FY27 Earnings Conference Call | nse |
| 31 Jul, 12:40 pm | — | … | Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Board Meeting Intimation For Declaration Of Quarterly Results For The Quarter Ended June 30, 2026 | bse |
| 20 Jul, 05:18 pm | — | … | Marksans Pharma Limited has informed the Exchange about acquisition of 100 percent share capital of ABCnow GmbH. | nse |
| 20 Jul, 05:15 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement Under Regulation 30 (LODR)- Updates | bse |
| 17 Jul, 03:37 pm | — | … | Marksans Pharma Limited has informed the Exchange about Second 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK" Phase IV | nse |
| 17 Jul, 03:35 pm | — | … | Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK" | bse |
| 08 Jul, 10:13 am | — | … | Marksans Pharma Limited has informed the Exchange regarding a press release dated July 08, 2026, titled "Marksans Pharma signed a definitive agreement to acquire 100 percent share capital of a German based Company namely ABCnow GmbH". | nse |
| 08 Jul, 10:07 am | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 03 Jul, 12:45 pm | — | … | Marksans Pharma Limited has informed the Exchange about General Updates regarding Record Date 20 August 2026 for payment of dividend. | nse |
| 03 Jul, 12:42 pm | — | … | Marksans Pharma Limited has informed the Exchange about General Updates regarding Annual General Meeting scheduled to be held on 27 August 2026. | nse |
| 03 Jul, 12:38 pm | — | … | Marksans Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 20-Aug-2026. | nse |
| 03 Jul, 12:34 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend | bse |
| 03 Jul, 12:30 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Dividend Updates | bse |
| 03 Jul, 12:23 pm | — | … | Marksans Pharma Ltd - 524404 - The Board Fixed 20 August 2026 As The Record Date For Ascertaining The Members Of The Company For Payment Of Dividend. | bse |
| 03 Jul, 12:18 pm | — | … | Marksans Pharma Ltd - 524404 - Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Annual General Meeting Related Matters | bse |
| 03 Jul, 12:05 pm | — | … | Marksans Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 20-Aug-2026. | nse |
| 03 Jul, 12:02 pm | — | … | Marksans Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 03, 2026. | nse |
| 26 Jun, 02:35 pm | — | … | Marksans Pharma Limited has informed the Exchange regarding 'Machine Readable Form / Legible copy of Financial Results'. | nse |
| 26 Jun, 12:37 pm | — | … | Marksans Pharma Ltd - 524404 - Updates | bse |
| 23 Jun, 04:37 pm | — | … | Marksans Pharma Limited has informed the Exchange about Second 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"'. | nse |
| 23 Jun, 04:34 pm | — | … | Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK" | bse |
| 16 Jun, 02:48 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement Under Regulation 30 (LODR)- Updates | bse |
| 16 Jun, 02:44 pm | — | … | Marksans Pharma Limited has informed the Exchange about Update on acquisition of QliniQ B.V. | nse |
| 09 Jun, 03:11 pm | rating_action | 2 | India Ratings and Research revised the outlook on Marksans Pharma’s bank loan facilities to Positive from Stable. | nse |
| 08 Jun, 02:53 pm | — | … | Marksans Pharma Limited has informed the Exchange about Schedule for Virtual Investor Conference | nse |
| 03 Jun, 02:26 pm | — | … | Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results | nse |
| 03 Jun, 02:23 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 02 Jun, 12:46 pm | — | … | Marksans Pharma Limited has informed the Exchange about Second 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"'. | nse |
| 02 Jun, 12:42 pm | — | … | Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK" | bse |
| 01 Jun, 09:01 am | — | … | Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". | nse |
| 01 Jun, 08:57 am | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 May, 06:54 pm | — | … | Marksans Pharma Limited has informed the Exchange about Audio Recording of investor(s) / analyst(s) meet Conference Call on Q4 FY26 Financial Results | nse |
| 27 May, 06:52 pm | — | … | Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 27 May, 05:59 pm | — | … | Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Audited Financial Results for the financial year ended 31 March, 2026 | nse |